8-Azaadenosine
8-Azaadenosine is a potent ADAR1 inhibitor and an A-to-I editing inhibitor. 8-Azaadenosine blocks RNA editing and inhibits proliferation, 3D growth, invasion, and migration in thyroid cancer cells[1][2].
Product Specifications
CAS Number
10299-44-2
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Adenosine Deaminase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/8-azaadenosine.html
Concentration
10mM
Purity
99.94
Solubility
DMSO : 250 mg/mL (ultrasonic) |H2O : 3.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
NC1=NC=NC2=C1N=NN2[C@@H]3O[C@@H]([C@H]([C@H]3O)O)CO
Molecular Formula
C9H12N6O4
Molecular Weight
268.23
Precautions
H315, H319, H335
References & Citations
[1]Maria Anna Zipeto, et al. ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis. Cell Stem Cell. 2016 Aug 4;19 (2) :177-191.|[2]Julia Ramírez-Moya, et al. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity. Oncogene. 2020 Apr;39 (18) :3738-3753.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HP216935 200 Reactions
PRMT10 (PRMT9) Human qPCR Primer Pair (NM_138364)
Sign In for Pricing
View Details 
BNC740521-100 1x 100 µL
AFP (Alpha Fetoprotein) (MBS-12), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 